Effect of a specific Escherichia coli Nissle 1917 strain on minimal/mild hepatic encephalopathy treatment

Table 2 The percentage of patients with hepatic encephalopathy and concomitant changes in the microflora under treatment with lactulose, rifaximin and EcN (n = 14 in each group)

Group of microflora	Percentage of patients with dysbiotic disorders, %
	Lactulose group		Rifaximin group		EcN group
	Before treatment	After treatment	Before treatment	After treatment	Before treatment	After treatment
Bifidobacteria	78.6	57.1a	71.4	42.9a	85.7	28.6a,b
Lactobacilli	64.3	42.9a	57.1	35.7a	57.1	21.4a,b
E.coli with normal properties	28.6	28.6	35.7	28.6	35.7	7.1a,b
E.coli with altered properties	28.6	21.4	28.6	14.3a	28.6	0.0a,b
Pathogenic enterobacteria	35.7	28.6	35.7	21.4a	35.7	0.0a,b
Candida	42.9	35.7	50.0	28.6a	50.0	7.1a,b
A change in at least one group of microorganisms was revealed	85.7	71.4a	92.9	64.3a	92.9	28.6a,b

^aP < 0.05 as compared to pre-treatment levels.

^bP < 0.05 as compared to the lactulose treatment.